Ironwood Pharmaceuticals (IRWD) Debt Ratio (2013 - 2026)

Ironwood Pharmaceuticals has disclosed Debt Ratio across 13 years of filings, most recently posting 1.35 for Q1 2026.

• Debt Ratio for Q1 2026 came in at 1.35, up 14.38% year-over-year; the trailing twelve-month figure through Mar 2026 was 1.35 (up 14.38% YoY), and the FY2025 annual result was 1.47, up 34.27% from the prior year.
• Debt Ratio came in at 1.35 for Q1 2026 at Ironwood Pharmaceuticals, down from 1.47 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 1.7 in Q2 2025 to a low of 0.11 in Q1 2022.
• The 5-year median for Debt Ratio is 1.08 (2024), against an average of 1.12.
• Across the five-year window, Debt Ratio grew 2.64% in 2024 and soared 58.61% in 2025, its largest moves.
• Ironwood Pharmaceuticals' Debt Ratio stood at 0.11 in 2022, then surged by 852.8% to 1.06 in 2023, then rose by 3.46% to 1.1 in 2024, then soared by 34.27% to 1.47 in 2025, then declined by 8.64% to 1.35 in 2026.
• The last three Debt Ratio figures came in at 1.35 (Q1 2026), 1.47 (Q4 2025), and 1.48 (Q3 2025), per Business Quant data.